These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1662091)

  • 1. Enhancement of ELISA cut-off reduces HCV-Ab false-positivity in patients with HBV, HDV and alcoholic liver disease.
    Andreone P; Cursaro C; Miniero R; Stefanini GF; Sprovieri G; Gasbarrini G
    Ital J Gastroenterol; 1991 Dec; 23(9):567-8. PubMed ID: 1662091
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevalence of HBV surface antigens, anti-HBD and anti-HCV antibodies in patients with virus-related chronic liver disease].
    Ozyilkan E; Tatar G; Köseoğlu T; Ozkuyumcu C; Kayhan B; Telatar H
    Mikrobiyol Bul; 1993 Oct; 27(4):308-13. PubMed ID: 7505386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevalence and clinical importance of antibodies to hepatitis B virus and hepatitis C virus in patients with alcoholic liver disease].
    Goeser T; Theilmann L
    Z Gastroenterol; 1992 Apr; 30(4):279-80. PubMed ID: 1318621
    [No Abstract]   [Full Text] [Related]  

  • 4. Detection of hepatitis C virus antibodies and hepatitis C virus RNA in patients with alcoholic liver disease.
    Nishiguchi S; Kuroki T; Yabusako T; Seki S; Kobayashi K; Monna T; Otani S; Sakurai M; Shikata T; Yamamoto S
    Hepatology; 1991 Dec; 14(6):985-9. PubMed ID: 1660025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of oral fluid for hepatitis C antibody screening.
    Sherman KE; Creager RL; O'Brien J; Sargent S; Piacentini S; Thieme T
    Am J Gastroenterol; 1994 Nov; 89(11):2025-7. PubMed ID: 7524312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hepatitis C and chronic alcoholic hepatopathy].
    Pagani A; Sala N; Zigliani P; Galante T
    Recenti Prog Med; 1994 Sep; 85(9):429-32. PubMed ID: 7938874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hepatitis C virus antibodies in alcoholic patients].
    González Quintela A; Alende R; Aguilera A; Tomé S; Gude F; Pérez Becerra E; Torre A; Martínez Vázquez JM; Barrio E
    Rev Clin Esp; 1995 Jun; 195(6):367-72. PubMed ID: 7644783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Infections with hepatitis B, C and delta viruses in patients with AIDS].
    Stazka J; Babiuch L; Mian M; Szymańska B; Kamińska E; Panfist E; Kowalska T; Poznańska-Linde H
    Przegl Epidemiol; 1991; 45(4):343-6. PubMed ID: 1668702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of antibody to hepatitis C virus (anti-HCV) in chronic liver diseases (CLD) in southern Italy.
    Amitrano L; Ascione A; Canestrini C; D'Agostino S; Iaccarino L; Vacca C; Gigliotti T
    Ital J Gastroenterol; 1990 Feb; 22(1):16-8. PubMed ID: 1966702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular epidemiological and clinical aspects of hepatitis D virus in a unique triple hepatitis viruses (B, C, D) endemic community in Taiwan.
    Lu SN; Chen TM; Lee CM; Wang JH; Tung HD; Wu JC
    J Med Virol; 2003 May; 70(1):74-80. PubMed ID: 12629646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of hepatitis C virus antibodies and hepatitis C virus RNA in patients with alcoholic liver disease.
    Bode JC; Alscher DM; Wisser H; Bode C
    Alcohol Alcohol; 1995 Jan; 30(1):97-103. PubMed ID: 7748281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infection with hepatitis A, B, C, and delta viruses among patients with acute hepatitis in Mongolia.
    Tsatsralt-Od B; Takahashi M; Endo K; Buyankhuu O; Baatarkhuu O; Nishizawa T; Okamoto H
    J Med Virol; 2006 May; 78(5):542-50. PubMed ID: 16555292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C-related hepatocellular carcinoma. Prevalence and significance.
    Resnick RH; Koff R
    Arch Intern Med; 1993 Jul; 153(14):1672-7. PubMed ID: 7687423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia.
    Tsatsralt-Od B; Takahashi M; Nishizawa T; Endo K; Inoue J; Okamoto H
    J Med Virol; 2005 Dec; 77(4):491-9. PubMed ID: 16254981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Seroprevalence of hepatitis C in human immunodeficiency virus infected patients].
    Ranger S; Aussel L; Weinbreck P; Loustaud V; Rogues AM; Mounier M; Delpeyroux C; Denis F
    Pathol Biol (Paris); 1991 Feb; 39(2):126-30. PubMed ID: 1901984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interpretation of Ortho HCV Ab ELISA test results by chiron HCV recombinant immunoblot assay].
    Yahagi N; Kitsugi K
    Rinsho Byori; 1991 Jan; 39(1):26-33. PubMed ID: 1848912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-hepatitis C virus antibodies in monoclonal gammopathy: an appraisal using the second generation tests.
    Marson P; Vicarioto M; De Silvestro G; Tenderini ML; Nardo G; Ongaro G
    Haematologica; 1992; 77(2):188. PubMed ID: 1328000
    [No Abstract]   [Full Text] [Related]  

  • 18. [Diagnosis of hepatitis C virus infection].
    Mateos M; Teruel JL; Nash R; Fernández Lucas M
    Enferm Infecc Microbiol Clin; 1991 Dec; 9(10):662. PubMed ID: 1668299
    [No Abstract]   [Full Text] [Related]  

  • 19. Does hepatitis C contribute to liver injury in alcohol abusers in the west of Scotland?
    Bird GL; Tibbs CJ; Orton D; Hillan KJ; MacSween RN; Williams R; Mills PR
    Eur J Gastroenterol Hepatol; 1995 Feb; 7(2):161-3. PubMed ID: 7536113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of HBsAg, anti-HCV and anti-HDV positivity in diverse groups].
    Doğanay M; Patiroğlu T; Utaş C; Ozbakir O; Unal A; Utaş S; Aygen B; Yücesoy M
    Mikrobiyol Bul; 1993 Apr; 27(2):107-12. PubMed ID: 7684812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.